CLSDのニュース
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians 2023/04/05 11:05:00 GlobeNewswire
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), today announced the appointment of Arshad M. Khanani, M.D., M.A, F.A.S.R.S and Lejla Vajzovic, M.D., F.A.S.R.S to its Scientific Advisory Board (SAB).
Clearside Biomedical Inc. (NASDAQ:CLSD) Drops -9.24%, But Further Rally Could Be Imminent 2023/03/11 14:00:00 Marketing Sentinel
In last trading session, Clearside Biomedical Inc. (NASDAQ:CLSD) saw 0.5 million shares changing hands with its beta currently measuring 2.11. Company’s recent per share price level of $1.08 trading at -$0.11 or -9.24% at ring of the bell on the day assigns it a market valuation of $59.86M. That closing price of CLSD’s stock is … Clearside Biomedical Inc. (NASDAQ:CLSD) Drops -9.24%, But Further Rally Could Be Imminent Read More »
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday 2023/03/10 12:13:37 Benzinga
Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD ) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to $5.51 in pre-market trading. Telsey Advisory Group raised the price target for Ulta Beauty, Inc. (NASDAQ: ULTA ) from $575 to $600. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating on the stock. Ulta Beauty shares fell 1.3% to $513.00 in pre-market trading. Needham cut the price target for Clearside Biomedical, Inc. (NASDAQ: CLSD ) from $5 to $4. Needham analyst Serge Belanger maintained a Buy rating. Clearside Biomedical shares fell 3.3% to close at $1.19 on Thursday. Barclays boosted the price target for United Airlines Holdings, Inc. (NASDAQ: … Full story available on Benzinga.com
Clearside Biomedical, Inc. (CLSD) Q4 2022 Earnings Call Transcript 2023/03/10 01:22:03 Seeking Alpha
Clearside Biomedical, Inc. (NASDAQ:NASDAQ:CLSD) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ETCompany ParticipantsJenny Kobin - Investor RelationsGeorge Lasezkay - President and…
Clearside Biomedical GAAP EPS of -$0.16 misses by $0.04, revenue of $0.3M beats by $0.2M 2023/03/09 21:34:15 Seeking Alpha
Clearside Biomedical press release (NASDAQ:CLSD): Q4 GAAP EPS of -$0.16 misses by $0.04.Revenue of $0.3M (-98.8% Y/Y) beats by $0.2M.
Clearside Biomedical, Inc.''s (CLSD) CEO George Lasezkay on Q1 2022 Results - Earnings Call Transcript 2022/05/12 01:11:06 Seeking Alpha
Clearside Biomedical, Inc. (NASDAQ:NASDAQ:CLSD) Q1 2022 Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - President…
Clearside Biomedical GAAP EPS of -$0.13 misses by $0.10, revenue of $0.35M misses by $5.85M 2022/05/11 20:12:03 Seeking Alpha
Clearside Biomedical press release (NASDAQ:CLSD): Q1 GAAP EPS of -$0.13 misses by $0.10.Revenue of $0.35M (+1066.7% Y/Y) misses by $5.85M.
Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update 2022/05/11 20:05:00 GlobeNewswire
- First Approved Suprachoroidal Product, XIPERE ® , Now Commercially Available in U.S. -
Clearside Biomedical Q1 2022 Earnings Preview (NASDAQ:CLSD) 2022/05/10 21:35:05 Seeking Alpha
Clearside Biomedical (CLSD) is scheduled to announce Q1 earnings results on Wednesday, May 11th, after market close.The consensus EPS Estimate is -$0.01 and the consensus Revenue…
Clearside Biomedical to Report First Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, May 11, 2022 2022/04/29 11:05:00 GlobeNewswire
ALPHARETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that its first quarter 2022 financial results will be reported on Wednesday, May 11, 2022 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.
Clearside Biomedical Inc. (NASDAQ:CLSD) Stock Ripped -21.09% Year-To-Date, What Will Happen Next? 2022/04/09 18:00:00 Marketing Sentinel
In last trading session, Clearside Biomedical Inc. (NASDAQ:CLSD) saw 0.36 million shares changing hands with its beta currently measuring 2.09. Company’s recent per share price level of $2.17 trading at -$0.2 or -8.44% at ring of the bell on the day assigns it a market valuation of $127.70M. That closing price of CLSD’s stock is … Clearside Biomedical Inc. (NASDAQ:CLSD) Stock Ripped -21.09% Year-To-Date, What Will Happen Next? Read More »
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference 2022/04/06 11:05:00 GlobeNewswire
ALPHARETTA, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at the Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 3:45 p.m. ET.
Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners? 2022/03/28 13:31:00 Benzinga
NEW YORK , March 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ORIC, WIMI, CLSD, SDIG, and GLOP. … Full story available on Benzinga.com
Bausch Health, Clearside launch vision disorder therapy Xipere in US 2022/03/28 12:15:52 Seeking Alpha
Bausch Health (BHC) and Clearside Biomedical (CLSD) launched eye disorder therapy Xipere (triamcinolone acetonide injectable suspension) in the U.S.The companies said Xipere is the…
Clearside Biomedical Inc. (NASDAQ: CLSD) Is One Of The Hottest Stocks Right Now. 2022/03/22 15:30:00 Stocks Register
Clearside Biomedical Inc. (NASDAQ:CLSD) price closed lower on Monday, March 21, dropping -10.31% below its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A look at the daily price movement shows that the last close reads $2.62, with intraday deals fluctuated between $2.33 and $2.7124. … Clearside Biomedical Inc. (NASDAQ: CLSD) Is One Of The Hottest Stocks Right Now. Read More »